$RDAR: Raadr Inc., Doing Business as Telvantis, Announces

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams
152
$RDAR: Raadr Inc., Doing Business as Telvantis, Announces Completion of PCAOB Audit for Financial Statements 2023 and 2024, Confirms Revenue Target for the Year 2025 in the Range of $250-300 Million.

NEW YORK - May 14, 2025 (NEWMEDIAWIRE) - Raadr Inc. (OTC: $RDAR), doing business as Telvantis ("Telvantis" or the "Company" , today announced the completion of its annual audit for the years 2023 and 2024.

The audit of the Company's Financial Statements was conducted in accordance with the standards of the Public Company Accounting Oversight Board (United States) ("PCAOB" .

"This audit is a major step for us as an emerging company with high aspirations. The team worked extremely hard, and we were able to complete this complex project in April," said Daniel Contreras, CEO of Telvantis. "We believe this is another building block to gain the trust of market participants and investors."

"These audited financial statements provide the highest standard of transparency to all our shareholders, as required for all public companies listed on a major US stock exchange," said Daniel Gilcher, CFO of Telvantis. "By implementing proper processes and holding ourselves to a PCAOB standard, we ensure that we provide the market with accurate and reliable information about our Company."

The audited financial statements are available for viewing at https://telvantis.com/investors/financial-sta...d-reports/ and are discussed by management below.

Consolidated Statement of Operations

The newly formed group reported revenues of $47 million for the year 2024 compared to $315.5 million in the prior year. This drop was mainly attributed to the lack of available working capital financing. The gross profit amounted to $2.28 million in 2024 compared to $16.97 million in the prior year. The Company reduced its General and administrative spending to $4.2m in 2024, down from $5.2 million in the year prior, as a result of ongoing restructuring efforts throughout 2024. Sales and Market expenses dropped significantly to $0.6 million, down more than $2 million from $2.65 million in the year before.
Importantly, the Company in its Irish subsidiary decided to write off a large receivable, which resulted in a one-off credit loss expense in total of $25.1 million for 2024 compared to a non-cash expense for Credit loss expense of $1.15 million in 2023.
Total operating expenses, including costs of goods sold, amounted to $74.7 million compared to $307.5 million in the year prior. This reduction is again a direct function of our limited sales activity in 2024. These activities resulted in a Loss from operations of $27.7 million, including the $25.1 million write-off for 2024, and Income from Operations of $7.9 million for the year 2023. Interest expenses dropped by more than $3.5m to $3.1 million for the year 2024, compared to $6.6 million in the year prior. The year 2024, therefore, resulted in a Net Loss of $28.7 million for the group compared to a positive Net Income of $1.6 million in 2023.

Consolidated Balance Sheet

The Company ended the year 2024 with $1.4 million in Cash and equivalents, compared to 0.09 million on December 31, 2023. Accounts receivable, after substantial write-offs, amounted to $33.4 million at the end of 2024, compared to $72.9 million on December 31, 2023. Total current assets stood at $35.2 million at the end of 2024, compared to $74.2 million at the end of 2023. In 2024, the Company recorded a deferred tax asset of $2.2 million as a result of its substantial write-off, compared to $0.1 million in such assets at the end of the prior year 2023. The company's intangible assets, net of amortization, stood at $11 million on December 31, 2024, compared to $12.4 million the year before.
Loan receivables from related parties amounted to $2.5 million at the end of 2024, compared to $4.5 million the year before. Total assets arrive at $54.6 million as of the balance sheet date in 2024 and $96.3 million as of December 31, 2024. This reduction is driven by both the write-off of receivables as well as the overall reduction in business activity through the year 2024. The Company's Accounts payable stood at $ 27.7 million at the end of 2024, down from $43.3 million the year before.
Current loans payable were down to $7.1 million at the end of 2024, down from $ 46.2 million at the end of 2023. This reduction is driven by the restructuring of this facility as a long-term liability through 2024. Total Current Liabilities therefore decreased to $36.2 million by December 31, 2024, from $90.2 million as of December 31, 2023.
Vice versa, Noncurrent loans payable stood at $ 41 million at the end of 2024. Total liabilities amounted to $82.2 million by the end of 2024, down $12.1 million from $94.3 million on the same day of the prior year. As a result, the Company's equity turned negative to $27.6 million compared to $1.9 million positive equity as of December 31, 2023.

Consolidated Statement of Cash Flows

The Company reported negative operating cash flows of $0.5 million for the year 2024, compared to negative $14 million in the prior year. The Company received $2.4 million in proceeds from loan receivables in 2024, compared to $3.3 million over the same period in 2023. Therefore, Net Cash used in Investing Activities amounted to $2.3 million for 2024, compared to $1.9 million in 2023. Cash Flow from Financing Activities amounted to negative $22 thousand for the year 2024, compared to positive $9.6 million driven by long-term debt issuance in 2023. Overall, the Company increased Cash and Cash Equivalents by $1.3 million during 2024 compared to a reduction of the same by $2.4 million during 2023.

"2024 was a challenging year for the group with both operational headwinds and the group restructuring under Telvantis. Nevertheless, the 2024 results are disappointing. However, the steps we have taken to bring the business back on track are already showing impact in our 2025 financial performance," commented Daniel Contreras.

"We have taken a conservative approach to write-offs, which negatively impacted our P/L in 2024. This is consistent with our approach to setting up the Company for long-term success. The executive team remains very confident in Telvantis' prospects. At this point, we can also confirm the revenue target discussed earlier this year in the range of $250-300 million," added Daniel Gilcher.

About TelvantisRaadr, Inc., doing business as Telvantis (OTC: $RDAR), is a U.S.-based communications technology company powering global enterprise communication. Leveraging extensive carrier relationships and proprietary CPaaS capabilities, Telvantis delivers high-volume, reliable messaging, voice, and digital communication solutions. With a strong foothold and expanding partnerships in high-growth sectors like fintech, healthcare, and e-commerce, Telvantis is executing its strategy to become a leader in the communications technology space. The company is headquartered in Miami Beach, FL.

Forward-looking statements

This press release contains forward-looking statements that involve risks and uncertainties. These statements reflect Telvantis' current expectations regarding future events and are based on management's beliefs and assumptions. Actual results could differ materially from those projected due to various factors, including market conditions, competition, and the successful integration of acquired operations. Investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Telvantis undertakes no obligation to update or revise any forward-looking statements, except as required by law.

Investor Relations contactRaadr Inc., doing business as Telvantis
1680 Michigan Avenue, Suite 700
Miami Beach, FL 33139
Email: ir@telvantis.com
Website: www.telvantis.com
Twitter/X: @Telvantis
LinkedIn: Telvantis

View the original release on www.newmediawire.com

Raadr Inc. (RDAR) Stock Research Links

RDAR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

4Roots Picks MSG for IT & Cybersecurity Support

Updated Category News Views 0

Tech-Boost for a Community Farm Vision Seems like everyone's buzzing about sustainability these days, and why not? It's the way forward. Take 4Roots and their Farm Campus initiative in Orlando. They've hooked up with Managed Services Group (MSG) to bolster their tech backbone, raising the stakes for their mission to shake up the food system. It's a no-nonsense...

Continue Reading
Better's 90-Day Plan: Growth Amidst Governance Gamble

Updated Category News Views 0

Unpacking the Ambitious 90-Day Plan When you hear Vishal Garg's name next to a 90-day sprint plan, it's not your everyday boardroom shuffle—you know there's grit behind the screen. Better Home & Finance (BETR) is angling for a massive turnaround with its latest rollout, but whether it's all sizzle and no steak is what we're here to figure out. Financial Metrics and...

Continue Reading
Photronics Investors Must Act by Sept. 4, 2026 Deadline

Updated Category News Views 0

Action Time for Photronics Investors There's nothing like a looming deadline to get the adrenaline pumping, especially when you're staring down the barrel of a federal securities class action. Photronics, Inc. (NASDAQ: PLAB) has found itself tangled in legal webs, with the clock ticking down to September 4, 2026. That’s the deadline for investors to move on being the...

Continue Reading
TELUS Digital Shakes Up Dreamforce with Exclusive Session

Updated Category News Views 17

What's Cooking at Hotel Zetta? Ever see a company shake up an event like TELUS Digital is about to at Dreamforce 2026? Instead of the usual booth schmooze-fest at Moscone Center, these folks are camping at Hotel Zetta with a packed 'boutique' agenda. From September 15–16, they're rolling out serious insider sessions for the big brains in financial services, education,...

Continue Reading
Wise Group Investors Alert Ahead of Key Legal Deadline

Updated Category News Views 0

Sizing Up the Legal Stakes for Wise Group Alright, here's a doozy that's bound to get your attention if you've got a stake in Wise Group plc (NASDAQ: WSE). We're talking about a looming securities class action, with the deadline to get involved barreling down like a runaway freight train. Before September 29, 2026, to be exact—mark it, circle it, do whatever you have to...

Continue Reading
PLAY Palm Angels Launches at Pacsun with Avani Gregg

Updated Category News Views 3

Revamping Streetwear with PLAY Palm Angels and Pacsun In a move that's making waves from the fashion runways straight into the heart of youth culture, PLAY Palm Angels is swooping into Pacsun, and they’re not just strolling in—they’re parading with a 41-piece fashion collection. Not to mention, they've snagged Avani Gregg, a powerhouse cultural influencer, to strut...

Continue Reading
Tahoe Truckee Life TV Series Elevates Local Flavor

Updated Category News Views 2

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...

Continue Reading
Catholic Colleges Excel in AI Readiness, Study Shows

Updated Category News Views 3

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Continue Reading
Médunik Canada Boosts Dravet Syndrome Support with Biocodex

Updated Category News Views 1

Breaking Down the Exclusive Médunik-Biocodex Partnership Listen, when a company like Médunik Canada, firmly rooted in Blainville, QC, throws its weight behind a rare disease drug like Diacomit®, folks in the industry take notice. Their recent handshake with Biocodex isn't just small talk; it opens doors to change how Dravet syndrome is managed across Canada. This new...

Continue Reading
EzCheckPrinting Boosts Remote Check Solutions Cost-Effectively

Updated Category News Views 1

Navigating the Check Printing Landscape Let's dive right into the changing realities of the workspace. With remote work becoming the new standard, small businesses are juggling tighter budgets while trying to maintain smooth financial operations. It's a hard game, but here is where Halfpricesoft.com rolls out their newly upgraded multi-user ezCheckPrinting software,...

Continue Reading

Top 5 Most Recently Viewed Articles

Uncovering Legal Options for MoonLake Immunotherapeutics Investors

Updated Category News Views 185

Overview of MoonLake Immunotherapeutics Class Action Investors in MoonLake Immunotherapeutics (NASDAQ: MLTX) have recently found themselves facing significant challenges. The disclosures regarding the company’s operations and the marketing of its products have prompted questions about the integrity of the information provided to shareholders. Why a Class Action? In a...

Continue Reading
BioCryst Sells European ORLADEYO Business for $250 Million

Updated Category News Views 184

BioCryst Concludes Successful Sale of European ORLADEYO Business In a significant move, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has confirmed the successful sale of its European ORLADEYO business to Neopharmed Gentili. This transaction is valued at $250 million and includes the potential for up to $14 million in future milestones linked to sales across Central and...

Continue Reading
Investors of Edwards Lifesciences Urged to Seek Legal Counsel

Updated Category News Views 200

Overview of Investor Rights in the Edwards Lifesciences Case In today's financial landscape, safeguarding your investments is paramount. Edwards Lifesciences Corporation (NYSE: EW) has emerged as a notable player in the healthcare sector, particularly in innovative heart valve therapies. However, recent events have raised concerns among shareholders, prompting calls for...

Continue Reading
Accuray Unveils Innovative Radiotherapy Solution for Cancer Care

Updated Category News Views 174

Revolutionizing Radiotherapy with Accuray Stellar Accuray, a leader in adaptive radiotherapy, has launched the Accuray Stellar™ Solution, which is designed to transform cancer care. This innovative solution offers an expansive toolbox that empowers clinical teams to adapt treatments to fit each patient's unique needs. Accuray's commitment to enhancing radiotherapy...

Continue Reading
Scale Computing Shines on Prestigious AI 100 Awards List

Updated Category News Views 191

Scale Computing Shines on Prestigious AI 100 Awards List Scale Computing, the market leader in edge computing and hyperconverged solutions, has recently made waves in the tech industry by being recognized on the annual CRN AI 100 list. This list marks a milestone as it celebrates companies that are at the forefront of innovation in artificial intelligence. Understanding...

Continue Reading